Ming Sun
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Circular RNAs in diseases 3
- Glycosylation and Glycoproteins Research 2
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- Shu Wang (4 shared papers)Shufang Nie (4 shared papers)Naïma Moustaïd‐Moussa (2 shared papers)Jia Zhang (2 shared papers)Rui Su (1 shared paper)Dayong Wu (1 shared paper)Wenyan Zhao (7 shared papers)Ruiwen Zhang (1 shared paper)
- Journals
- Surgical Oncology (2 papers)Oncotarget (1 paper)Journal of Cardiovascular Pharmacology (1 paper)Cellular Oncology (1 paper)Planta Medica (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ming Sun
49 papers receiving 1.5k citations
Ming Sun's Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Medicine 151
- Biochemistry 166
- Pharmaceutical Science 130
- Complementary and alternative medicine 124
- Biomaterials 188
Countries citing papers authored by Ming Sun
This map shows the geographic impact of Ming Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Sun more than expected).
Fields of papers citing papers by Ming Sun
This network shows the impact of papers produced by Ming Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Sun. The network helps show where Ming Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals Hit paper breakdown → | 2013 | 434 |
| 2 | 2013 | 224 | |
| 3 | 2020 | 146 | |
| 4 | 2013 | 115 | |
| 5 | 2018 | 63 | |
| 6 | 2007 | 50 | |
| 7 | 2014 | 50 | |
| 8 | 2019 | 42 | |
| 9 | 2017 | 40 | |
| 10 | 2021 | 37 | |
| 11 | 2011 | 34 | |
| 12 | 2023 | 34 | |
| 13 | 2016 | 29 | |
| 14 | 2020 | 27 | |
| 15 | 2012 | 24 | |
| 16 | 2015 | 22 | |
| 17 | Withaferin-A induces apoptosis in osteosarcoma U2OS cell line via generation of ROS and disruption of mitochondrial membrane potential. | 2017 | 21 |
| 18 | 2009 | 21 | |
| 19 | 2018 | 18 | |
| 20 | 2022 | 16 |
About Ming Sun
Ming Sun is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Oncology and Biomaterials, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Circular RNAs in diseases (3 papers), Glycosylation and Glycoproteins Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Seaweed-derived Bioactive Compounds (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Advanced X-ray and CT Imaging (2 papers) and Polysaccharides and Plant Cell Walls (2 papers). The work is most often cited by research in Molecular Medicine (151 citations), Biochemistry (166 citations), Pharmaceutical Science (130 citations), Complementary and alternative medicine (124 citations) and Biomaterials (188 citations). Ming Sun has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Shu Wang, Shufang Nie, Naïma Moustaïd‐Moussa, Jia Zhang, Rui Su, Dayong Wu, Wenyan Zhao, Ruiwen Zhang, Zhaoyang Fan and Xuan Pan. Their work appears in journals such as Surgical Oncology, Oncotarget, Journal of Cardiovascular Pharmacology, Cellular Oncology and Planta Medica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.